Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

We report on a patient with cranio-cervical dystonia injected with the new, lower protein formulation of botulinum toxin A who developed secondary resistance to this toxin. Subsequent injections with botulinum toxin B provided substantial reduction of blepharospasm. This is the first reported case of secondary resistance to the new preparation of botulinum toxin A.

Original languageEnglish
Pages (from-to)1098-1100
Number of pages3
JournalMovement Disorders
Volume17
Issue number5
DOIs
StatePublished - Sep 2002

Keywords

  • Botulinum toxin A
  • Secondary resitance

Fingerprint Dive into the research topics of 'Secondary nonresponsiveness to new bulk botalinum toxin A (BCB2024)'. Together they form a unique fingerprint.

Cite this